These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12669964)

  • 1. Effect of colonic lactulose availability on the timing of drug release onset in vivo from a unique colon-specific drug delivery system (CODES).
    Yang L; Watanabe S; Li J; Chu JS; Katsuma M; Yokohama S; Fix JA
    Pharm Res; 2003 Mar; 20(3):429-34. PubMed ID: 12669964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on lactulose formulations for colon-specific drug delivery.
    Katsuma M; Watanabe S; Kawai H; Takemura S; Masuda Y; Fukui M
    Int J Pharm; 2002 Dec; 249(1-2):33-43. PubMed ID: 12433432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro evaluation of dissolution behavior for a colon-specific drug delivery system (CODES) in multi-pH media using United States Pharmacopeia apparatus II and III.
    Li J; Yang L; Ferguson SM; Hudson TJ; Watanabe S; Katsuma M; Fix JA
    AAPS PharmSciTech; 2002; 3(4):E33. PubMed ID: 12916927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
    Kshirsagar SJ; Bhalekar MR; Umap RR
    Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline.
    Mura P; Maestrelli F; Cirri M; González Rodríguez ML; Rabasco Alvarez AM
    J Drug Target; 2003 Jul; 11(6):365-71. PubMed ID: 14668057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scintigraphic evaluation of a novel colon-targeted delivery system (CODES) in healthy volunteers.
    Katsuma M; Watanabe S; Takemura S; Sako K; Sawada T; Masuda Y; Nakamura K; Fukui M; Connor AL; Wilding IR
    J Pharm Sci; 2004 May; 93(5):1287-99. PubMed ID: 15067705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-specific drug delivery for mebeverine hydrochloride.
    Omar S; Aldosari B; Refai H; Gohary OA
    J Drug Target; 2007 Dec; 15(10):691-700. PubMed ID: 18041637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
    Varum FJ; Hatton GB; Freire AC; Basit AW
    Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new index, the core erosion ratio, of compression-coated timed-release tablets predicts the bioavailability of acetaminophen.
    Sawada T; Sako K; Fukui M; Yokohama S; Hayashi M
    Int J Pharm; 2003 Oct; 265(1-2):55-63. PubMed ID: 14522118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between gelation rate of controlled-release acetaminophen tablets containing polyethylene oxide and colonic drug release in dogs.
    Sako K; Nakashima H; Sawada T; Fukui M
    Pharm Res; 1996 Apr; 13(4):594-8. PubMed ID: 8710752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
    Akhgari A; Sadeghi F; Garekani HA
    Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery.
    Akhgari A; Afrasiabi Garekani H; Sadeghi F; Azimaie M
    Int J Pharm; 2005 Nov; 305(1-2):22-30. PubMed ID: 16236475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colonic release and reduced intestinal tissue damage of coated tablets containing naproxen inclusion complex.
    Piao ZZ; Lee MK; Lee BJ
    Int J Pharm; 2008 Feb; 350(1-2):205-11. PubMed ID: 17928177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vitro and in vivo performance of a colonic delivery system.
    Ahmed IS; Ayres JW
    Int J Pharm; 2011 May; 409(1-2):169-77. PubMed ID: 21382462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro release and in vivo absorption in beagle dogs of meloxicam from Eudragit FS 30 D-coated pellets.
    Gao C; Huang J; Jiao Y; Shan L; Liu Y; Li Y; Mei X
    Int J Pharm; 2006 Sep; 322(1-2):104-12. PubMed ID: 16806752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and development of release modulated colon targeted system of meloxicam for potential application in the prophylaxis of colorectal cancer.
    Patel MM; Amin AF
    Drug Deliv; 2011 May; 18(4):281-93. PubMed ID: 21138335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges.
    Jain V; Singh R
    Arch Pharm Res; 2011 May; 34(5):733-40. PubMed ID: 21656358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tailoring of drug delivery of 5-fluorouracil to the colon via a mixed film coated unit system.
    Kumar RV; Sinha VR
    Acta Pharm; 2011 Sep; 61(3):343-51. PubMed ID: 21945913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
    Liu F; Moreno P; Basit AW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.